Sunhawk Vision Biotech, Inc. (TPEX:7759)
Taiwan · Delayed Price · Currency is TWD 31.20
+1.20 (4.00%)
At close: Jul 13, 2026
Sunhawk Vision Biotech Company Description
Sunhawk Vision Biotech, Inc., a drug development company, engages in the research and development of children's myopia eye drops, dry eye drops, and other nucleic acid new drugs for the treatment of ocular surface diseases in Taiwan.
The company develops SHJ002 eye drops, which have completed a Phase 2 clinical trial for the treatment of dry eye disease in adult patients and corneal erosion in patients with Sjogren’s syndrome, as well as in a Phase 2 clinical trial for myopia control in young children.
Sunhawk Vision Biotech, Inc. was founded in 2019 and is based in Taipei, Taiwan.
Sunhawk Vision Biotech, Inc.
| Country | Taiwan |
| Founded | 2019 |
| Industry | Biotechnology |
| Sector | Healthcare |
Contact Details
Address: No.66, Sanchong Road Taipei, 115602 Taiwan | |
| Phone | 886 2 2711 4597 |
| Website | sunhawkvision.com |
Stock Details
| Ticker Symbol | 7759 |
| Exchange | Taipei Exchange |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Suh-Hang Juo | Founder and Chairman |
| Dr. Chung-Ling Liang | Founder, Vice President, Chief Medical Officer and Director |
| Hao-Yu Lin | Vice President, Accounting Supervisor and Chief Financial Officer |